Every nephrologist knows about serum creatinine, eGFR, albuminuria, proteinuria. We use them to assess disease activity. But do we really assess disease activity with them? eGFR can be low and albuminuria or proteinuria can be high because of chronic and potentially irreversible changes, like glomerulosclerosis and tubulointerstitial fibrosis, changes that might not be amenable to treatment. How do we know which patient needs more treatment if what we are picking up with established markers might be fibrosis. Well, these questions might become old-fashioned quickly. Let us introduce you to DKK3, a new urine biomarker which could finally identify patients with ongoing kidney injury that might benefit from more treatment. Have a listen to our new ERA podcast with Danilo Fliser, explaining what DKK3 is and why we should all probably begin measuring it.

Most of us have gone to medical universities to become doctors, and physicians, to be the people who diagnose and treat patients. At some point, however, we all realize that we’re also the ones that are supposed to do the medical research which does not come naturally to many of us. If you can relate to what has just been said, we have the right answers for you, ladies and gentlemen. Have a listen to our new ERA podcast with the editors of NDT and CKJ, Hans-Joachim Anders and Jürgen Floege. Listen to them being honest about what kind of research they would like to see in journals and how to make your work more presentable. The amount of pearls shared could fill a whole necklace. You don’t believe me? Check it out.

Let's start with a quiz. Which was the most research in the World on Google for 2023? Yes, of course. Artificial intelligence. A super hot topic. Things are going ready fast, and the text, the videos, the images, the books but what about the medicine? What about the nephrology? Is it coming? Is it already here? If you want to know more about it, check us out in the ERA podcast with Roser Torra, ERA President coming from Fundació Puigvert, Spain.